Form 4: cbdMD Director Sybil Swift Reports Acquisition and Disposal of Common Stock
SEC Form 4 Filing
Director Sybil Swift reports acquiring and disposing of cbdMD, Inc. common stock and restricted stock units.
Summary
- On May 16, 2025, Sybil Swift, a director of cbdMD, Inc., reported acquiring 1,572 shares of common stock and disposing of 2,573 shares.
- The acquisition of 1,572 shares was related to restricted stock units.
- The restricted stock units vest quarterly on June 30, 2025, September 30, 2025, December 31, 2025, and March 31, 2026.
- These units were issued under the 2021 Equity Compensation Plan as compensation for her services on the Board of Directors.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The filing provides transparency to shareholders regarding director stock transactions.
Key Dates
| Date | Description |
|---|---|
| 05/16/2025 | Date of transaction: acquisition and disposal of common stock and restricted stock units. |
| 05/20/2025 | Date of signature. |
| 06/30/2025 | First quarterly vesting date for restricted stock units. |
| 09/30/2025 | Second quarterly vesting date for restricted stock units. |
| 12/31/2025 | Third quarterly vesting date for restricted stock units. |
| 03/31/2026 | Final quarterly vesting date for restricted stock units. |
Keywords
Form 4, Beneficial Ownership, Director, Sybil Swift, cbdMD, YCBD, Restricted Stock Units, Equity Compensation Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.